Glutathione S-Transferase M1 (GSTM1) Deficiency and Lung Cancer Risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 4, Issue 6, 1995, Pages 589-594

  Harris, Emily L ^c   Richert Boe, Kathryn E ^a   Henner, William David ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b FLINDERS UNIVERSITY   (Australia)

^c CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ARTICLE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME DEFICIENCY; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; GENE EXPRESSION; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; LUNG NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0029114981     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Hanawalt, P. C., and Sarasis, A. Cancer prone hereditary diseases with DNA processing abnormalities. Trends Genet., 2: 124–129, 1990.
2. Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Jr, Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., and Friend, S. H. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233–1238, 1990.
3. Wingo, P. A., Tong, T., and Bolden, S. Cancer Statistics. CA Cancer J. Clin., 45: 8–30, 1995.
4. Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., and Lucier, G. W. Genetic risk and carcinogen exposure: a common inherited defect of carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder carcinoma. J. Natl. Cancer Inst., 85: 1159–1164, 1993.
5. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S. I. Germ line polymorphisms of p53 and CYPJA1 genes involved in human lung cancer. Carcinogenesis (Lond.), 14: 1085–1089, 1993.
6. Mannervik, B. The isoenzymes of glutathione transferase. Adv. Enzym. Relat. Areas Mol. Biol., 57: 357–417, 1985.
7. Ketterer, B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res., 202: 343–361, 1988.
8. Fryer, A. A., Zhao, L., Alldersea, J., Boggild, M. D., Perrett C. W., Clayton R. N., Jones, P. W., and Strange, R. C. The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. Carcinogenesis (Lond.), 14: 563–566, 1993.
9. Board, P. G. Biochemical genetics of glutathione 5-transferase in man. Am. J. Hum. Genet., 33: 36–43, 1981.
10. Seidegård, J., and Pero, R. W. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum. Genet., 69: 66–68, 1985.
11. Seidegård, J., Pero, R. W., Miller, D. G., and Beattie, E. J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis (Lond.), 7: 751–753, 1986.
12. Greenland, S. Quantitative methods in the review of epidemiologic literature. Epidemiol. Rev., 9: 1–30. 1987.
13. Schlesselman, J. J. Case-Control Studies: Design, Conduct, Analysis. New York: Oxford University Press, 171–226, 1982.
14. Irwig, L., Tosteson, A. N. A., Gatsonis, C., Lau, J., Colditz, G., Chalmers, T. C., and Mosteller, F. Guidelines for meta-analyses evaluating diagnostic tests. Ann. Intern. Med., 120: 667–676, 1994.
15. Shea, T. C., Claflin, G., Comstock, K. E., Sanderson, B. J. S., Burstein, N. A., Keenan, E. J., Mannervik, B., and Henner, W. D. Glutathione transferase activity and isoenzyme composition in primary human breast cancers. Cancer Res., 50: 6848–6853, 1990.
16. Strange, R. C., Faulder, C. G., Davis, B. A., Hume, R., Brown, J. A. H., Cotton, W., and Hopkinson, D. A. The human glutathione S-transferases: studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes. Ann. Hum. Genet., 48: 11–20, 1984.
17. Howie, A. F., Miller, W. R., Hawkins, R. A., Hutchinson, A. R., and Beckett, G. J. Expression of glutathione S-transferase B1 B2, μ and Π in breast cancers and their relationship to oestrogen receptor status. Br. J. Cancer, 60: 834–837, 1989.
18. Lewis, A. D., Forrester, L. M., Hayes, J. D., Wareing, C. J., Carmichael, J., Harris, A. L., Mooghen, M., and Wolf, C. R. Glutathione S-transferase isoenzymes in human tumors and tumor derived cell lines. Br. J. Cancer, 60: 327–331, 1989.
19. Lafuente, A., Giralt, M., Cervello, I., Pujol, F., and Mallol, J. Glutathione S-transferase activity in human superficial transitional cell carcinoma of the bladder: comparison with healthy controls. Cancer (Phila.), 65: 2064–2068, 1990.
20. Peters, W. H. M., Kock, L., Nagengast, F. M., and Roelofs, H. M. J. Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem. Pharmacol., 39: 591–597, 1990.
21. Seidegård, J., Pero, R. W., Markowitz, M. M., Roush, G., Miller, D. G., and Beattie, E. J. Isoenzymes of glutathione transferase (class μ.) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis (Lond.), 11: 33–36, 1990.
22. Clapper, M. L., Hoffman, S. J., and Tew, K. D. Glutathione S-transferases in normal and malignant human colon tissue. Biochim. Biophys. Acta, 1096: 209–216, 1991.
23. Strange, R. C., Matharoo, B., Faulder, G. C., Jones, P., Cotton, W., Elder, J. B., and Deakin, M. The human glutathione S-transferascs: a case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis (Lond.), 12: 25–28, 1991.
24. Zhong, S., Howie, A. F., Ketterer, B., Taylor, J., Hayes, J. D., Beckett, G. J., Wathen, C. G., Wolf, C. R., and Spurr, N. K. Glutathione S-transferase μ. locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis (Lond.), 12: 1533–1537, 1991.
25. Hayashi, S-I., Watanabe, J., and Kawajiri, K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and p-class glutathione S-transferase genes. Jpn. J. Cancer Res., 83: 866–870, 1992.
26. Heckbert, S. R., Weiss, N. S., Homung, S. K., Eaton, D. L., and Motulsky, G. Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J. Natl. Cancer Inst., 84: 414–422, 1992.
27. Strange, R. C., Fryer, A. A., Matharoo, B., Zhao, L., Broome, J., Campbell, D. A., Jones, P., Pastor, I. C., and Singh, R. V. P. The human glutathione 5-transferases: comparison of isoenzyme expression in normal and astrocytoma brain. Biochim. Biophys. Acta, 1139: 222–228, 1992.
28. Albin, N., Masaad, L., Toussaint, C., Mathieu, M-C., Morizet, J., Parise, O., Gouyette, A., and Chabot, G. G. Main drug-metabolizing enzyme systems in human breast tumors and peri-tumoral tissues. Cancer Res., 53: 3541–3546, 1993.
29. Brockmöller, J., Kerb, R., Drakoulis, N., Nitz, M., and Roots, I. Genotype and phenotype of glutathione S-transferase class μ. isoenzymes μ. and ψ in lung cancer patients and controls. Cancer Res., 53: 1004–1011, 1993.
30. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., and Vainio, H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis (Lond.), 14: 1479–1481, 1993.
31. Hollstein, M. C., Wild, C. P., Bleichcr, F., Chutimatacwin, S., Harris, C. C., Srivatanakul, P., and Montesano, R. p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int. J. Cancer, 53: 51–55, 1993.
32. Kihara, M., Noda, K., and Okamoto, N. Increased risk of lung cancer in Japanese smokers with class p. glutathione S-transferase gene deficiency. Cancer Lett., 71: 151–155, 1993.
33. Lafuente, A., Pujol, F., Carretero, P., Villa, J. P., and Cuchi, A. Human glutathione S-transferase μ. (GST-μ.) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett., 68: 49–54, 1993.
34. Lin, H. J., Han, C. Y., Bernstein, D. A., Hsiao, W., and Hardy, S. The common glutathione S-transferase (GST) μ gene deletion: ethnic distribution in 1,204 individuals and frequency in bladder cancer patients (Abstract). Am. Soc. Hum. Genet., 53 (Suppl.): 824, 1993.
35. McGlynn, K. A., Hu, Y., Shen, F. M., Chen, G. C., Xia, X. L., Rosvold, E. A., and Buetow, K. H. Association of glutathione S-transferase p genotype and liver cancer (Abstract). Am. Soc. Hum. Genet., 53 (Suppl.): 832, 1993.
36. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphisms of the CYPIAI and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994–2999, 1993.
37. Nazar-Stewart, V., Motulsky, A. G., Eaton, D. L., White, E., Hornung, S. K., Leng, Z-T., Stapelton, P., and Weiss, N. S. The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res., 53: 2313–2318, 1993.
38. Peters, W. H. M., Wobbes, T., Roelofs, H. M. J., and Jansen, J. B. M. J. Glutathione S-transfcrases in esophageal cancer. Carcinogenesis (Lond.), 14: 1377–1380, 1993.
39. Rebbeck, T. R., Rosvold, E. A., McGlynn, K. A., Lustbader, E. D., and Buetow, K. H. Association of breast cancer with genotypes encoding phase I and II detoxification enzymes (Abstract). Am. Soc. Hum. Genet., 53 (Suppl.): 847, 1993.
40. Strange, R. The glutathione 5-transferase GSTM1 0 locus and cancer susceptibility. In: K. D. Tew, C. B. Pickett, T. J. Mantle, B. Mannervik, and J. D. Hayes (eds.). Structure and Function of Glutathione Transferases, pp. 175–186. Boca Raton, FL: CRC Press, 1993.
41. Zhong, S., Hayes, J. D., Spurr, N. K., and Wolf, C. R. Molecular genetics of the human μ class GST gene family. In: K. D. Tew, C. B. Pickett, T. J. Mantle, B. Mannervik, and J. D. Hayes (eds.). Structure and Function of Glutathione Transferases. Boca Raton, FL: CRC press, 147–159, 1993.
42. Zhong, S., Wyllie, A. H., Barnes, D., Wolf, C. R., and Spurr, N. K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (Lond.), 14: 1821–1824, 1993.
43. Alexandrie, A-K., Sundberg, M. I., Seidegård, J., Tornling, G., and Rannug, A. Genetic susceptibility to lung cancer with special emphasis on CYPIAI and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis (Lond.), 15: 1785–1790, 1994.
44. Kihara, M., Kihara, M., and Noda, K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis (Lond.), 15: 415–418, 1994.
45. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphisms of the CYPIAI and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994–2999, 1993.
46. Brockmöller, J., Gross, D., Kerb, R., Drakoulis, N., and Roots, I. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class μ gene detected by polymerase chain reaction. Biochem. Pharmacol., 43: 647–650, 1992.
47. Silverberg, E. Cancer Statistics. CA Cancer J. Clin., 29: 6–21, 1979.
48. Peters, W. H. M., Roelofs, H. M. J., vanPutten, W. L. J., Klijn, J. G. M., and Foekens, J. A. Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br. J. Cancer, 68: 86–92, 1993.
49. Krontiris, T. G., Devlin, B., Karp, D. D., Robert, N. J., and Risch, N. An association between the risk of cancer and mutations in the HRASI minisatellite locus. N. Engl. J. Med., 329: 517–523, 1993.